rss
Ann Rheum Dis 62:1145-1155 doi:10.1136/ard.2003.011742
  • Extended report

EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT)

  1. K M Jordan10,
  2. N K Arden1,
  3. M Doherty5,
  4. B Bannwarth2,
  5. J W J Bijlsma3,
  6. P Dieppe4,
  7. K Gunther7,
  8. H Hauselmann8,
  9. G Herrero-Beaumont9,
  10. P Kaklamanis11,
  11. S Lohmander14,
  12. B Leeb12,
  13. M Lequesne13,
  14. B Mazieres15,
  15. E Martin-Mola16,
  16. K Pavelka17,
  17. A Pendleton18,
  18. L Punzi19,
  19. U Serni,
  20. B Swoboda21,
  21. G Verbruggen22,
  22. I Zimmerman-Gorska23,
  23. M Dougados6
  1. 1Nigel Arden, Southampton General Hospital, Southampton S016 6YD, UK
  2. 2Bernard Bannwarth, Laboratoire de Thérapeutique, Université Bordeaux II, 33076 Bordeaux Cedex, France
  3. 3Johannes Bijlsma, Department of Rheumatology and Immunology, University Hospital Utrecht, 3508 Utrecht GA, The Netherlands
  4. 4Paul Dieppe, MRC Health Services Research Collaboration, University of Bristol, Canynghe Hall, Whiteladies Road, Bristol BS8 2PR, UK
  5. 5Michael Doherty, Rheumatology Unit R.U.G., City Hospital, Nottingham NG5 1PB, UK
  6. 6Maxime Dougados, Service de Rheumatologie B, Hôpital Cochin, 75014 Paris, France
  7. 7Klaus-Peter Gunther, Department of Orthopaedic Surgery, University of Dresden, D-Dresden, Germany
  8. 8Hans Hauselmann, Centre for Rheumatology and Bone Disease, Clinic Im Park, Hirslanden Group, Bellariast. 38, CH 8038 Zurich, Switzerland
  9. 9Gabriel Herrero-Beaumont, Rheumatology Department, Clinique de la Conception, 28040 Madrid, Spain
  10. 10Kelsey Jordan, Florence Cottage, 17 Dover Street, Southampton SO146GG, UK
  11. 11Phaedon Kaklamanis, 16 Anaperon Polemon, 11521 Athens, Greece
  12. 12Burkhard Leeb, NÖ Zentrum für Rheumatology, Stockerau Hospital, A-2000 Stockerau, Austria
  13. 13Michel Lequesne, 31-33 rue Guillemot, 75014 Paris, France
  14. 14Stefan Lohmander, Deparment of Orthopaedics, University Hospital, S-22185 Lund, Sweden
  15. 15Bernard Mazieres, Service de Rhumatologie, 1 avenue Jean Poulhès, CHU Rangueil, 31054 O, Cedex France
  16. 16Emilio Martin-Mola, Divisione di Reumatologia, Hosptial La Paz, 28046 Madrid, Spain
  17. 17Karel Pavelka, Institute of Rheumatology, 12850 Praha 2, Czech Republic
  18. 18Adrian Pendleton, 9 Prince Edward Drive, Stranmillis, Belfast BT9 5GB, Northern Ireland
  19. 19Leonardo Punzi, Universita degli studi di Padova, Policlinico Universitario - VIII Piano, Via Giustiniani, 2, 35128 Padova, Italy
  20. 20Umberto Serni, Divisione di Reumatologia, Istituto Ortopedico Toscano, Florence, Italy
  21. 21Berndt Swoboda, Ortopedik Poliklinik der Universität Erlangen-Nuremberg, D-91054 Erlangen, Germany
  22. 22Gust Verbruggen, Rheumatology Unit, U.Z R.U.G., B-7000 Gent, Belgium
  23. 23Irena Zimmermann-Gorska, Department of Rheumatology and Rehabilitation, Karol Marcinkowski University of Medical Sciences, 28 Czerwca 1956r, 135/147, 61-545 Poznan, Poland
  1. Correspondence to:
    Professor M Dougados
    Institut de Rhumatologie, Hardy B, Hopital Cochin 27, rue du Faubourg Saint-Jacques, 75014 Paris, France; m.dougcch.ap-hop-paris.fr
  • Accepted 21 July 2003

Abstract

Objectives: To update the EULAR recommendations for management of knee osteoarthritis (OA) by an evidence based medicine and expert opinion approach.

Methods: The literature search and guidelines were restricted to treatments for knee OA pertaining to clinical and/or radiological OA of any compartment of the knee. Papers for combined treatment of knee and other types of OA were excluded. Medline and Embase were searched using a combination of subject headings and key words. Searches for those treatments previously investigated were conducted for January 1999 to February 2002 and for those treatments not previously investigated for 1966 to February 2002. The level of evidence found for each treatment was documented. Quality scores were determined for each paper, an effect size comparing the treatment with placebo was calculated, where possible, and a toxicity profile was determined for each treatment modality.

Results: 497 new publications were identified by the search. Of these, 103 were intervention trials and included in the overall analysis, and 33 treatment modalities were identified. Previously identified publications which were not exclusively knee OA in the initial analysis were rejected. In total, 545 publications were included. Based on the results of the literature search and expert opinion, 10 recommendations for the treatment of knee OA were devised using a five stage Delphi technique. Based on expert opinion, a further set of 10 items was identified by a five stage Delphi technique as important for future research.

Conclusion: The updated recommendations support some of the previous propositions published in 2000 but also include modified statements and new propositions. Although a large number of treatment options for knee OA exist, the evidence based format of the EULAR Recommendations continues to identify key clinical questions that currently are unanswered.

Footnotes